Rodent models for autism: A critical review

Drug Discovery Today: Disease Models

Volumn 2, Issue 2, 2005, Pages 93-101

  Belzung, Catherine ^a   Leman, Samuel ^a   Vourc'h, Patrick ^a   Andres, Christian ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; AMISULPRIDE; AMPHETAMINE DERIVATIVE; BROMOCRIPTINE; CLOMIPRAMINE; CLONIDINE; CLOZAPINE; DESIPRAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; NALTREXONE; PIMOZIDE; PROPRANOLOL; RISPERIDONE; SERTRALINE;

ANIMAL BEHAVIOR; AUTISM; BEHAVIOR MODIFICATION; COGNITION; COMMUNICATION DISORDER; DISEASE MODEL; DISEASE SIMULATION; HUMAN; NONHUMAN; RAT STRAIN; REVIEW; SOCIAL BEHAVIOR; STEREOTYPY; TRANSGENIC MOUSE;

EID: 21844448615     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2005.05.004     Document Type: Review

References (56)

1. L.Y. Tsai Psychopharmacology in autism Psychosom. Med. 61 1999 651-665
2. S.J. Moore et al. A clinical study of 57 children with fetal anticonvulsant syndromes J. Med. Genet. 37 2000 489-497
3. W.T. McKinney Jr et al. Animal model of depression. I. Review of evidence: Implications for research Arch. Gen. Psychiatry 21 1969 240-248
4. J. Bachevalier Medial temporal lobe structures and autism: A review of clinical and experimental findings Neuropsychologia 32 1994 627-648
5. M. Engelmann et al. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats Physiol. Behav. 55 1994 145-149
6. S.M. Gardiner et al. The cardiovascular and renal responses to short-term isolation in Brattleboro rats Clin. Sci. (Lond.) 64 1983 377-382
7. I.F. Bielsky et al. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice Neuropsychopharmacology 29 2004 483-493
8. S.R. Wersinger et al. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice Mol. Psychiatry 7 2002 975-984
9. S.R. Wersinger et al. Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task Horm. Behav. 46 2004 638-645
10. G.J. De Vries et al. Brain sexual dimorphism and sex differences in parental and other social behaviors Ann. N. Y. Acad. Sci. 807 1997 273-286
11. L.J. Young et al. Neuroendocrine bases of monogamy Trends Neurosci. 21 1994 71-75
12. J.T. Winslow et al. Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse Horm. Behav. 37 2000 145-155
13. E. Choleris et al. An estrogen-dependent four-gene micronet regulating social recognition: A study with oxytocin and estrogen receptor-alpha and -beta knockout mice Proc. Natl. Acad. Sci. USA 100 2003 6192-6197
14. J.N. Ferguson et al. Social amnesia in mice lacking the oxytocin gene Nat. Genet. 25 2000 284-288
15. J.N. Ferguson et al. Oxytocin in the medial amygdala is essential for social recognition in the mouse J. Neurosci. 21 2001 8278-8285
16. M. Kavaliers et al. Impaired discrimination of and aversion to parasitized male odors by female oxytocin knockout mice Genes Brain Behav. 2 2003 220-230
17. A. Moles et al. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene Science 304 2004 1983-1986
18. D. Kahne et al. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism Physiol. Behav. 75 2002 403-410
19. T. Schneider et al. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism Neuropsychopharmacology 30 2005 80-89
20. M.V. Pletnikov et al. Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders Front. Biosci. 7 2002 d593-d607
21. M. Hornig et al. An infection-based model of neurodevelopmental damage Proc. Natl. Acad. Sci. USA 96 1999 12102-12107
22. S. Bobee et al. Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat Behav. Brain Res. 112 2000 107-117
23. G. Wolterink et al. Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders Eur. Neuropsychopharmacol. 11 2001 51-59
24. L. Diergaarde et al. Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat Neuroscience 130 2005 581-590
25. M. Schneider et al. Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: Effects of chronic pubertal cannabinoid treatment Neuropsychopharmacology 30 2005 80-89
26. J.P. Vicedomini et al. Role of residual anterior neocortex in recovery from neonatal prefrontal lesions in the rat Physiol. Behav. 28 1982 797-806
27. Y.S. Mineur et al. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse Hippocampus 12 2002 39-46
28. N. Lijam et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1 Cell 90 1997 895-905
29. W.L. Salinger et al. Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation Behav. Neurosci. 117 2003 1257-1275
30. J. Podhorna et al. The heterozygous reeler mouse: Behavioural phenotype Behav. Brain Res. 153 2004 43-54
31. J. Caston et al. An animal model of autism: Behavioural studies in the GS guinea pig Eur. J. Neurosci. 10 1998 2677-2684
32. T.R. Insel Mouse models for autism: Report from a meeting Mamm. Genome 12 2001 755-757
33. C. Andres Molecular genetics and animal models in autistic disorder Brain Res. Bull. 57 2002 109-119
34. J.N. Crawley Designing mouse behavioral tasks relevant to autistic-like behaviors Ment. Retard. Dev. Disabil. Res. Rev. 10 2004 248-258
35. M.M. Lim et al. Neuropeptides and the social brain: Potential rodent models of autism Int. J. Dev. Neurosci. 23 2005 235-243
36. T.H. Wassink et al. Examination of AVPR1a as an autism susceptibility gene Mol. Psychiatry 9 2004 968-972
37. R.S. Yeung et al. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene Proc. Natl. Acad. Sci. USA 91 1994 11413-11416
38. K. Miura et al. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice Neurobiol. Dis. 9 2002 149-159
39. T.M. DeLorey et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome J. Neurosci. 18 1998 8505-8514
40. H. Waage-Baudet et al. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: Implications for autism Int. J. Dev. Neurosci. 21 2003 451-459
41. T. Jacks et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 Nat. Genet. 7 1994 353-361
42. J. Guy et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome Nat. Genet. 27 2001 322-326
43. A.L. Joyner et al. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox Science 251 1991 1239-1243
44. T.J. Hendricks et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior Neuron 37 2003 233-247
45. F.C. Zhou et al. Moderate alcohol exposure compromises neural tube midline development in prenatal brain Brain Res. Dev. Brain Res. 144 2003 43-55
46. K. Miyazaki et al. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism Int. J. Dev. Neurosci. 23 2005 287-297
47. E.D. Levin et al. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations Neurotoxicol. Teratol. 24 2002 733-741
48. Crawley, J.N. (2000) What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, p. 329, John Wiley and Sons
49. C. Belzung Measuring rodent exploratory behavior. In Handbook of Molecular Genetic Techniques for Brain and Behavior Research (W.E. Crusio R. Gerlai, eds) 2001 Elsevier 739-749
50. M.T. Palermo and P. Curatolo Pharmacologic treatment of autism J. Child Neurol. 19 2004 155-164
51. D. Feifel et al. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: A potential predictive model for novel antipsychotic effects Neuropsychopharmacology 29 2004 731-738
52. R. Ventura et al. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: Involvement of dopamine in the medial prefrontal cortex Behav. Pharmacol. 15 2004 433-442
53. G. Flores et al. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex J. Neurosci. 16 1996 7366-7375
54. M. Bennay et al. Neonatal medial prefrontal cortex lesion enhances the sensitivity of the mesoaccumbal dopamine system Eur. J. Neurosci. 19 2004 3277-3290
55. J.W. Bodfish Treating the core features of autism: Are we there yet? Ment. Retard. Dev. Disabil. Res. Rev. 10 2004 318-326
56. P. Chapillon et al. Effects of pre- and postnatal stimulation on developmental, emotional, and cognitive aspects in rodents: A review Dev. Psychobiol. 41 2002 373-387